Dupont De Nemours Inc SEC Filings

DuPont de Nemours, Inc. insider plans to sell common stock under Rule 144. A notice was filed to sell 72,958 shares of common stock through Merrill Lynch on the NYSE, with an aggregate market value of $2,993,940.97. The filing notes that 418,975,324 shares of this class are outstanding.

The shares to be sold were acquired mainly through employee stock option exercises and vesting of restricted stock units and performance share awards between 2020 and 2025 under the issuer’s equity compensation plans. During the past three months, the seller previously disposed of 43,208 common shares for gross proceeds of $3,334,079.77. By signing, the seller represents they are not aware of any undisclosed material adverse information about DuPont’s current or prospective operations.

DuPont de Nemours, Inc. reported a technical update related to its agreements following the spin-off of Qnity Electronics, Inc. effective November 1, 2025. DuPont and Qnity have now agreed that DuPont’s “Applicable Percentage” under their Separation and Distribution Agreement is 56%, which resets the “Minimum EBITDA” for DuPont to $1,400,000,000 under a related 2019 letter agreement with Corteva, Inc. They also agreed that Qnity’s Applicable Percentage is 44%. These percentages define how minimum earnings benchmarks are allocated between DuPont and Qnity after the spin-off.

DuPont de Nemours, Inc. reported a routine insider share acquisition by a director. On 11/26/2025, the director acquired 982.5051 shares of DuPont common stock at a price of $39.44 per share, as shown in Table I of the filing. Following this transaction, the director beneficially owned 34,421.4286 shares, held directly. The filing notes that this amount includes shares acquired through a dividend reinvestment program, meaning dividends were automatically used to buy additional stock rather than being paid in cash.

DuPont de Nemours, Inc. director reports additional share ownership through dividend reinvestment. A company director filed a Form 4 disclosing the acquisition of 1,267.7484 shares of DuPont common stock on 11/26/2025 at a price of $39.44 per share. The transaction increased the director’s directly held stake to 75,473.223 shares.

The filing notes that the new shares were acquired pursuant to a dividend reinvestment, meaning cash dividends were automatically used to purchase additional DuPont stock rather than being paid out in cash. The form indicates the holdings are owned directly and does not list any derivative securities transactions.

DuPont de Nemours, Inc. director reported a small increase in ownership through automatic dividend reinvestment. On 11/26/2025, the director acquired 206.0091 shares of DuPont common stock at a price of $39.44 per share. After this transaction, the director beneficially owns 19,578.8854 shares in total, held directly. The filing notes that the reported amount includes shares acquired through a dividend reinvestment program.

DuPont de Nemours, Inc. insider equity transaction: The company’s SVP & General Counsel reported an option exercise and share sale in DuPont common stock. On 11/28/2025, the executive exercised stock options covering 6,005 shares at an exercise price of $28 per share, converting them into common stock. On the same date, 6,005 common shares were sold at a price of $39.79 per share.

Following these transactions, the reporting person directly beneficially owned 112,101.1276 shares of DuPont common stock. The options exercised were part of a grant originally dated 02/03/2019, with an expiration date of 02/02/2026, and the remaining balance of these options is now reported as zero.

DuPont de Nemours, Inc. reported an insider transaction by its CEO and director on 11/28/2025. The reporting person exercised 9,011 stock options with an exercise price of $28 per share, acquiring the same number of DuPont common shares. On the same date, the insider sold 9,011 shares of common stock in an open-market transaction coded as a sale.

The sale had a weighted average price of $39.4619, with trades ranging from $39.46 to $39.48. Following these transactions, the insider directly beneficially owned 288,325.6878 shares of DuPont common stock. The stock options involved were non-qualified options granted on 02/03/2019 with an expiration date of 02/02/2026, vesting in three substantially equal annual installments.

DuPont de Nemours, Inc. has a shareholder filing a notice of proposed sale under Rule 144 for 6,005 shares of its common stock, with an aggregate market value of $238,968.98. The shares are expected to be sold on the NYSE through Merrill Lynch, with an approximate sale date of 11/28/2025. These 6,005 shares were acquired on the same date by exercising employee stock options through a broker-assisted cashless exercise, and are part of a total of 418,975,324 common shares outstanding.

DuPont de Nemours, Inc. insider plans to sell recently exercised shares under Rule 144. A holder intends to sell 9,011 shares of DuPont common stock through Merrill Lynch on the NYSE, with an aggregate market value of $355,591.21 as disclosed in the notice. The shares relate to DuPont, which had 418,975,324 common shares outstanding at the time referenced in the form.

The securities to be sold were acquired on 11/28/2025 through the exercise of employee stock options in a broker-assisted cashless transaction, meaning option exercise and sale are coordinated. The person for whose account the shares are to be sold represents that they are not aware of any material adverse, nonpublic information about DuPont’s current or prospective operations.